Clinical Trial Update: TMC435 HPC1004 - Phase I Study Investigating the Pharmacokinetics of TMC435 in Healthy Chinese Volunteers [Phase 1]

View source ↗

Summary

This Phase I pharmacokinetic study evaluated TMC435 in healthy Chinese volunteers and has completed, describing how the drug behaves in the body after administr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TMC435

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED